Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Emergence Delirium Prevention in Children Undergoing Tonsillectomy
NCT07704437Phase 1Completed
- Sponsor
- Clinical Hospital Center Split
- Start
- Apr 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, randomised trial of remimazolam in emergence delirium (ED) (2 arms), sponsored by Clinical Hospital Center Split. Primary endpoint: Pediatric Anesthesia Emergence Delirium scale. Started Apr 2024; status: completed.
02
Drugs
remimazolam
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT07704437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704437.